Financials Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2025-07-16 pm EDT 5-day change 1st Jan Change
113.43 USD +0.43% Intraday chart for Agilent Technologies, Inc. -6.49% -15.56%

Projected Income Statement: Agilent Technologies, Inc.

Forecast Balance Sheet: Agilent Technologies, Inc.

Fiscal Period: October 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 918 1,154 1,716 1,145 2,061 1,640 1,429 1,173
Change - 25.71% 48.7% -33.28% 80% -20.43% -12.87% -17.91%
Announcement Date 11/23/20 11/22/21 11/21/22 11/20/23 11/25/24 - - -
1USD in Million
Estimates

Cash Flow Forecast: Agilent Technologies, Inc.

Fiscal Period: October 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 119 188 291 298 378 444.4 369.1 354.1
Change - 57.98% 54.79% 2.41% 26.85% 17.57% -16.95% -4.05%
Free Cash Flow (FCF) 1 802 1,297 1,021 1,474 1,373 1,090 1,350 1,456
Change - 61.72% -21.28% 44.37% -6.85% -20.6% 23.82% 7.86%
Announcement Date 11/23/20 11/22/21 11/21/22 11/20/23 11/25/24 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Agilent Technologies, Inc.

Fiscal Period: October 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 25% 26.11% 29.95% 28.61% 30.38% 29.81% 30.66% 31.57%
EBIT Margin (%) 22.68% 24.1% 27.12% 27.44% 26.44% 26.45% 27.29% 28.27%
EBT Margin (%) 15.77% 21.52% 21.96% 19.6% 23.36% 23.03% 24.45% 24.89%
Net margin (%) 13.47% 19.15% 18.31% 18.15% 19.8% 18.82% 19.73% 20.85%
FCF margin (%) 15.02% 20.53% 14.91% 21.57% 21.09% 16.07% 18.85% 19.16%
FCF / Net Income (%) 111.54% 107.19% 81.42% 118.87% 106.52% 85.39% 95.53% 91.9%

Profitability

        
ROA 10.72% 13.1% 14.75% 15.08% 11.4% 12.44% 12.46% 12.77%
ROE 21.27% 25.96% 29.31% 28.34% 21.95% 24.99% 23.64% 23.83%

Financial Health

        
Leverage (Debt/EBITDA) 0.69x 0.7x 0.84x 0.59x 1.04x 0.81x 0.65x 0.49x
Debt / Free cash flow 1.14x 0.89x 1.68x 0.78x 1.5x 1.5x 1.06x 0.81x

Capital Intensity

        
CAPEX / Current Assets (%) 2.23% 2.98% 4.25% 4.36% 5.81% 6.55% 5.15% 4.66%
CAPEX / EBITDA (%) 8.91% 11.39% 14.19% 15.24% 19.11% 21.97% 16.81% 14.76%
CAPEX / FCF (%) 14.84% 14.49% 28.5% 20.22% 27.53% 40.76% 27.34% 24.32%

Items per share

        
Cash flow per share 1 2.952 4.869 4.373 5.986 6.017 4.651 6.491 -
Change - 64.94% -10.18% 36.89% 0.51% -22.7% 39.54% -
Dividend per Share 1 0.72 0.776 0.84 0.9 - 0.9833 1.035 1.14
Change - 7.78% 8.25% 7.14% - - 5.21% 10.21%
Book Value Per Share 1 15.62 17.84 17.75 19.75 20.27 23.24 26.87 30.84
Change - 14.25% -0.54% 11.26% 2.64% 14.69% 15.59% 14.78%
EPS 1 2.3 3.94 4.18 4.19 4.43 4.528 5.225 6.012
Change - 71.3% 6.09% 0.24% 5.73% 2.22% 15.39% 15.05%
Nbr of stocks (in thousands) 308,310 302,723 296,041 292,587 287,328 284,065 284,065 284,065
Announcement Date 11/23/20 11/22/21 11/21/22 11/20/23 11/25/24 - - -
1USD
Estimates
2025 *2026 *
P/E ratio 25x 21.7x
PBR 4.88x 4.22x
EV / Sales 4.99x 4.7x
Yield 0.87% 0.91%
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
113.43USD
Average target price
136.82USD
Spread / Average Target
+20.63%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A Stock
  4. Financials Agilent Technologies, Inc.